BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 24772414)

  • 1. Protein nanoparticles as drug delivery carriers for cancer therapy.
    Lohcharoenkal W; Wang L; Chen YC; Rojanasakul Y
    Biomed Res Int; 2014; 2014():180549. PubMed ID: 24772414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment.
    Wong KH; Lu A; Chen X; Yang Z
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery.
    Amreddy N; Babu A; Muralidharan R; Panneerselvam J; Srivastava A; Ahmed R; Mehta M; Munshi A; Ramesh R
    Adv Cancer Res; 2018; 137():115-170. PubMed ID: 29405974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sight on protein-based nanoparticles as drug/gene delivery systems.
    Salatin S; Jelvehgari M; Maleki-Dizaj S; Adibkia K
    Ther Deliv; 2015; 6(8):1017-29. PubMed ID: 26305428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Based Nanoparticles as Drug Delivery Systems.
    Hong S; Choi DW; Kim HN; Park CG; Lee W; Park HH
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32610448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Targeted Nanostructured Coordination Polymers (NCPs) for Cancer Therapy.
    Novio F
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
    Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Acid-Triggered Degradable and Fluorescent Nanoscale Drug Delivery System with Enhanced Cytotoxicity to Cancer Cells.
    An J; Dai X; Wu Z; Zhao Y; Lu Z; Guo Q; Zhang X; Li C
    Biomacromolecules; 2015 Aug; 16(8):2444-54. PubMed ID: 26213802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silk fibroin-based nanoparticles for drug delivery.
    Zhao Z; Li Y; Xie MB
    Int J Mol Sci; 2015 Mar; 16(3):4880-903. PubMed ID: 25749470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
    Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
    Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.